Form 4: Guardian Pharmacy Services Director Acquires Shares in Merger Transaction

Director John Ackerman reports acquisition of Class B Common Stock in Guardian Pharmacy Services following a merger, convertible to Class A Common Stock over time.

Summary

• John Ackerman, a director of Guardian Pharmacy Services, Inc., reported the acquisition of Class B Common Stock on September 27, 2024, as a result of a merger agreement.
• The merger involved Guardian Pharmacy Services, Inc., Guardian Merger Corp., and Guardian Pharmacy, LLC.
• Each common unit of Guardian Pharmacy, LLC (excluding those held by Guardian Investor, Inc.) was converted into one share of Class B common stock and the right to receive $1.02 in cash.
• Ackerman's holdings include shares held directly and indirectly through Pharmacy Investors, LLC and Cardinal Equity Fund LP.
• The Class B common stock will automatically convert into Class A common stock in four equal tranches on March 28, 2025, September 27, 2025, March 28, 2026, and September 27, 2026.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document is a standard regulatory filing related to a merger. It doesn't inherently indicate positive or negative sentiment.

Future Outlook

The Class B common stock will convert to Class A common stock in four equal tranches over the next two years, potentially impacting the share structure.

Industry Context

Form 4 filings are standard disclosures for corporate insiders, providing transparency into their transactions and holdings. This specific filing relates to a merger event, which is a common occurrence in the pharmaceutical services industry as companies consolidate and seek growth.

Stakeholder Impact

• Shareholders will see a change in the share structure as Class B shares convert to Class A shares over time.
• The merger itself may have broader implications for the company's strategy and performance, affecting all stakeholders.

Key Dates